Clinomics Inc
KOSDAQ:352770
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
New World Gold Corp
OTC:NWGC
|
US |
Clinomics Inc
Other
Clinomics Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Clinomics Inc
KOSDAQ:352770
|
Other
-₩285.8m
|
CAGR 3-Years
-131%
|
CAGR 5-Years
-145%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other
₩1.5T
|
CAGR 3-Years
163%
|
CAGR 5-Years
41%
|
CAGR 10-Years
28%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other
-₩539.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other
-₩23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other
-₩50.5m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Clinomics Inc
Glance View
Clinomics, Inc. conducts bio and medical research activities. The company is headquartered in Ulsan, Ulsan. The company went IPO on 2020-12-04. The firm's main businesses are multi-omics-based service business and liquid biopsy-based cancer diagnosis and screening business. The multi-omics-based service business provides products and services that predict physical characteristics and diseases based on genome diagnosis and tests, and provides early diagnosis services for major diseases such as cancer based on multi-omics. The liquid biopsy-based cancer diagnosis and screening business sells medical devices that diagnose patients by extracting blood cells and deoxyribonucleic acid (DNA), and diagnostic and monitoring kits for cancer mutations in patients. The company is also develops products that diagnoses cancer early with blood.
See Also
What is Clinomics Inc's Other?
Other
-285.8m
KRW
Based on the financial report for Dec 31, 2024, Clinomics Inc's Other amounts to -285.8m KRW.
What is Clinomics Inc's Other growth rate?
Other CAGR 5Y
-145%
Over the last year, the Other growth was 32%. The average annual Other growth rates for Clinomics Inc have been -131% over the past three years , -145% over the past five years .
